Steve Stiles

News

S-ICD ‘noninferior’ to transvenous-lead ICD in head-to-head PRAETORIAN trial

Author:: Steve Stiles

Publish date: May 11, 2020

Younger patients without heart failure “are the kind of patient who you would probably lean very strongly toward for an S-ICD rather than a transve...

News

Signature STEMI sign may be less diagnostic in the COVID-19 age

Author:: Steve Stiles

Publish date: April 22, 2020

ST-segment elevation, often a ticket to the cath lab, may not indicate STEMI as reliably as before hospitals star...

News

VICTORIA: Vericiguat seen as novel success in tough-to-treat, high-risk heart failure

Author:: Steve Stiles

Publish date: March 28, 2020

The relative risk reduction was modest, but experts say the benefit in absolute terms was remarkable for already well-treated patients.

News

Prescription cascade more likely after CCBs than other hypertension meds

Author:: Steve Stiles

Publish date: March 3, 2020

Prescribing a calcium-channel blocker to an elderly patient often leads to a loop diuretic scrip within months

News

Societies dig in to EXCEL trial controversy

Author:: Steve Stiles

Publish date: January 2, 2020

EACTS-ESC calls for evidence review and development of updated recommendations for left-main disease “as a matter of urgency.”

News

FDA panel rejects vernakalant bid for AFib cardioversion indication

Author:: Steve Stiles

Publish date: December 11, 2019

Eleven years after the first attempt of the antiarrhythmic agent, the FDA panel voted resoundingly against approval.

News

DAPA-HF: Dapagliflozin benefits regardless of age, HF severity

Author:: Steve Stiles

Publish date: November 25, 2019

PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.